Concepedia

Taro Iguchi

TI

Statistics

Publications

38

Citations

2.5K

H-Index

21

Active since

2004

Affiliations

Osaka City University(Current)

Pfizer (United States)

University of Tübingen

Astellas Pharma (United States)

P.A. Hertzen Moscow Oncology Research Institute

Taro Iguchi is an author at Osaka City University specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

2004–2025

38

Publications

38

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

, , +17

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Arun Azad, Taro Iguchi et al. · Journal of Clinical Oncology · 2022 · 299 citations · Full text

, , +17

Hyperintense plaque identified by magnetic resonance imaging relates to intracoronary thrombus as detected by optical coherence tomography in patients with angina pectoris

Shoichi Ehara, Tsuyoshi Hasegawa, Satoshi Nakata et al. · European Heart Journal - Cardiovascular Imaging · 2012 · 65 citations · Full text

, , +17

Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer

Yuji Takeyama, Minoru Kato, Satoshi Tamada et al. · Cancer Letters · 2020 · 60 citations · Full text

, , +17

Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan

Shinichi Sakamoto, Katsuhito Miyazawa, Takahiro Yasui et al. · International Journal of Urology · 2018 · 59 citations

, , +12

1–5 of 38